News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Chaz Goodwine

Chaz Goodwine is lead downstream scientist at AGC Biologics.

Articles by Chaz Goodwine

Станислав Чуб/Stock.adobe.com – a next generation convecdiff membrance was tested by AGC Biologics against a mAb created by the company.

Purification of Antibodies Using Novel Convecdiff Membranes Part 2: Robust Performance at Comparable Product Quality

ByChaz Goodwine,Katrin Töppner,Patrick Adametz,Ricarda A. Busse,Volkmar Thom

February 2nd 2023

In part 2 of this article, results from the testing of a next generation convecdiff membrane are discussed.

Siarhei/Stock.adobe.com – Convecdiff membranes are a novel material for downstream purification that has shown favorable results for scale-up from lab bench to commercial-scale application.

Purification of Antibodies Using Novel Convecdiff Membranes Part 1: Providing High Binding Capacity at Short Residence Time and Low Pressure Drops

ByKatrin Töppner,Patrick Adametz,Chaz Goodwine,Ricarda A. Busse,Volkmar Thom

January 2nd 2023

The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.

Latest Updated Articles

Purification of Antibodies Using Novel Convecdiff Membranes Part 1: Providing High Binding Capacity at Short Residence Time and Low Pressure Drops
Published: January 2nd 2023 | Updated:

Trending on BioPharm International

BioPharm Weekly News Roundup—Week of Oct. 13, 2025

Strategies for Building Tech Talent in the Biopharma Industry (Part 4)

Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D

© 2025 MJH Life Sciences^®

All rights reserved.